glimepiride and anagliptin

glimepiride has been researched along with anagliptin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bekki, M; Fukumoto, Y; Honda, A; Igata, S; Kodama, N; Kumashiro, Y; Nakamura, T; Oshige, T; Sugiyama, Y; Tahara, A; Tahara, N; Yamagishi, SI	1

Trials

1 trial(s) available for glimepiride and anagliptin

Article	Year
Anagliptin, A Dipeptidyl Peptidase-4 Inhibitor Ameliorates Arterial Stiffness in Association with Reduction of Remnant-Like Particle Cholesterol and Alanine Transaminase Levels in Type 2 Diabetic Patients. Current vascular pharmacology, 2016, Volume: 14, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Alanine Transaminase; Biomarkers; Blood Glucose; Cholesterol; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Female; Glycated Hemoglobin; Humans; Japan; Lipoproteins; Male; Middle Aged; Prospective Studies; Pyrimidines; Sulfonylurea Compounds; Time Factors; Treatment Outcome; Triglycerides; Vascular Stiffness	2016

Article

Year

Anagliptin, A Dipeptidyl Peptidase-4 Inhibitor Ameliorates Arterial Stiffness in Association with Reduction of Remnant-Like Particle Cholesterol and Alanine Transaminase Levels in Type 2 Diabetic Patients.

Current vascular pharmacology, 2016, Volume: 14, Issue:6

Topics: Adult; Aged; Aged, 80 and over; Alanine Transaminase; Biomarkers; Blood Glucose; Cholesterol; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Female; Glycated Hemoglobin; Humans; Japan; Lipoproteins; Male; Middle Aged; Prospective Studies; Pyrimidines; Sulfonylurea Compounds; Time Factors; Treatment Outcome; Triglycerides; Vascular Stiffness

2016